Search for: "Mylan, Inc."
Results 1 - 20
of 587
Sorted by Relevance
|
Sort by Date
5 Dec 2008, 5:31 am
By Mark Chael -- On December 2nd, Mylan, Inc. and Mylan Pharmaceuticals, Inc. announced that they had settled their dispute with Novartis Pharmaceuticals Corp., Novartis Corp., and Novartis International AG over a generic version of Novartis' Femara ® tablets.According to the press release, Femara ® tablets, which are used in the treatment of breast cancer, had U.S. sales of about $470 million for the 12 months ending September 30, 2008.… [read post]
17 Dec 2008, 5:54 am
The challenges to the '777 patent had been initiated by Defendants-Appellants Mylan Laboratories, Inc., Mylan Pharmaceuticals, Inc., and UDL Laboratories, Inc. [read post]
9 Jan 2020, 8:25 pm
Mylan Pharmaceuticals Inc. is recalling certain batches of its Nizatidine Capsules, USP, over concerns they may contain a carcinogen. [read post]
10 Jun 2009, 9:02 pm
Seeking approval to market a generic version of levofloxacin, Defendants-Appellants Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc. filed an Abbreviated New Drug Application (ANDA) with the FDA. [read post]
9 Nov 2021, 9:31 pm
Mylan Pharmaceuticals Inc. [read post]
7 Dec 2023, 9:59 pm
Mylan Pharmaceuticals Inc., with the Court vacating and remanding the District Court's claim construction for failure to consider extrinsic evidence. [read post]
6 Sep 2016, 3:36 pm
Schneiderman comes as Mylan is part of the widening backlash against Mylan's in response to its sharp increase in the price of the EpiPen, treatments for life-threatening anaphylactic shock. [read post]
20 Aug 2017, 7:14 am
Pharmaceutical companies Mylan Inc. and Mylan Specialty L.P. agree to pay $465 million to settle a lawsuit brought under the False Claims Act (FCA). [read post]
8 Dec 2021, 8:52 am
The outcome AstraZeneca AB and AstraZeneca Pharmaceuticals LP (collectively, “AstraZeneca”) sued Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P. [read post]
5 Oct 2022, 8:12 pm
Patent No. 7,326,708 were either anticipated or rendered obvious by the asserted prior art, in Mylan Pharmaceuticals Inc. v. [read post]
19 Oct 2016, 8:28 am
Department of Justice (DOJ) to reject the proposed $465 million settlement reached between the government and Mylan, Inc. after it was discovered the beleaguered corporation, responsible for increasing the price of the life-saving EpiPen to $600 per 2-pak in August of this The post DOJ Urged to Reject Mylan Settlement by Senator appeared first on Legal Reader. [read post]
11 Oct 2016, 12:22 pm
EpiPen maker Mylan, Inc. has been ripping off Medicare and Medicaid for years but is only now being held accountable for their unethical, unprofessional and deceitful practices; the company has agreed to pay the government $465 million for having overcharged both insurance providers by classifying their drug as “generic,” thus reducing their percentage of the The post Mylan to Pay $465 Million for Overcharging Medicaid appeared first on Legal Reader. [read post]
31 Dec 2010, 3:57 am
The drug maker Mylan Inc. has agreed to settle a lawsuit brought against it by both the U.S. government and the State of Texas. [read post]
24 Mar 2014, 1:42 pm
Mylan Inc. [read post]
8 Nov 2021, 9:15 am
Mylan Pharmaceuticals Inc. affirming a ruling of the District of Delaware, which dismissed a Hatch-Waxman lawsuit against related Mylan entities for either improper venue or failure to state a claim upon which relief could be granted. [read post]
18 Oct 2009, 5:42 pm
Teva announced that it has filed a lawsuit against Mylan Pharmaceuticals, Inc., Mylan Inc. and Natco Pharma Ltd. for patent infringement in the [...] [read post]
27 Apr 2008, 11:47 pm
Bresch, 38, works for Mylan Inc. [read post]
28 Oct 2016, 2:35 pm
Mylan N.V. recently “announced that its subsidiary, Mylan Inc., has agreed to the terms of a $465 million settlement with the U.S. [read post]
24 Oct 2008, 11:37 am
Swiss-drug major Novartis has filed a lawsuit in the US District Court for the District of New Jersey against Mylan Pharmaceuticals Inc. for infringement of Orange Book listed US Patent No. 5,354,772 (the ‘772 patent) for Lescol capsules, generically known as Fluvastatin Sodium. [read post]
2 May 2016, 6:17 am
The Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
